GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

159938 GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS

Closed 01-05 15:00:00

0.67

+0.02

+3.70%

High0.67	Low0.65	Vol57.85M
Open0.65	D1 Closing0.65	Amplitude3.85%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O38.46M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS","latestPrice":0.673,"timestamp":1767596637000,"preClose":0.649,"halted":0,"volume":57849900,"delay":0,"changeRate":0.037,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":0.024,"latestTime":"01-05 15:00:00","open":0.649,"high":0.674,"low":0.649,"amount":38456800,"amplitude":0.0385,"askPrice":0.674,"askSize":9789,"bidPrice":0.673,"bidSize":1619,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767663000000},"marketStatusCode":5,"adr":0,"adjPreClose":0.649,"symbolType":"fund","openAndCloseTimeList":[[1767576600000,1767583800000],[1767589200000,1767596400000]],"highLimit":0.714,"lowLimit":0.584,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.333909,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938/tweets","defaultTab":"tweets","newsList":[{"id":"1130695564","title":"Nyingchi Achieves Full Coverage of Tibetan Medicine Service Network, Total Industry Output Exceeds 1.3 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1130695564","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130695564?lang=en_us&edition=fundamental","pubTime":"2026-01-05 09:02","pubTimestamp":1767574928,"startTime":"0","endTime":"0","summary":"Recently, it was learned from the Nyingchi Municipal Health Commission that in recent years, the development of Traditional Chinese (Tibetan) Medicine in Nyingchi has yielded significant results. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"1113007708","title":"2026: Charting the Course for Pharmaceutical Commercial Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=1113007708","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113007708?lang=en_us&edition=fundamental","pubTime":"2026-01-04 20:31","pubTimestamp":1767529882,"startTime":"0","endTime":"0","summary":"Pharmaceutical commercial enterprises have often been \"invisible\" in the secondary market. In the final month of 2025, these companies captured significant attention—HeFu China emerged as a stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"1173788327","title":"Dual Medical and Commercial Insurance Directories Implemented, Brain-Computer Interfaces and Weight-Loss Targets Emerge: Where is the 2026 Pharmaceutical Boom?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173788327","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173788327?lang=en_us&edition=fundamental","pubTime":"2026-01-01 19:31","pubTimestamp":1767267070,"startTime":"0","endTime":"0","summary":"As the 2026 New Year dawned, Beijing was gripped by a severe chill. Yet, within the pharmaceutical sector, the focus on medical innovation continued to intensify. In December, the National Healthcare...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1515","09939","159938"],"gpt_icon":0},{"id":"1188690926","title":"Hong Kong Stock Market Tops Global IPO Fundraising Ranking for 2025, Pharmaceutical Sector Emerges as Key Pillar","url":"https://stock-news.laohu8.com/highlight/detail?id=1188690926","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188690926?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:11","pubTimestamp":1767183067,"startTime":"0","endTime":"0","summary":"After three years of deep correction, Hong Kong's innovative drug market surged back into a bull run in 2025, catalyzed by the massive $4.8 billion business development deal between 3SBio and Pfizer...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"1110450484","title":"Renfu Pharma's Formal Penalty Finalized, Investor Claims Filed for Case Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1110450484","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110450484?lang=en_us&edition=fundamental","pubTime":"2025-12-30 15:10","pubTimestamp":1767078640,"startTime":"0","endTime":"0","summary":"Affected investors can register their claims for this company on the Sina Investor Rights Protection Platform. On December 29, ST Renfu announced that the company and its controlling shareholder...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","159938","BK1161"],"gpt_icon":0},{"id":"1123914854","title":"Tax Incentive Extended for Cosmetics, Pharmaceuticals, and Beverage Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=1123914854","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123914854?lang=en_us&edition=fundamental","pubTime":"2025-12-30 14:02","pubTimestamp":1767074523,"startTime":"0","endTime":"0","summary":"Up to 30% of advertising and business promotion expenses can be deducted within the current year. The cosmetics, pharmaceutical, and beverage manufacturing sectors have received favorable policy...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","159938","BK1515"],"gpt_icon":0},{"id":"1195764847","title":"Shenwan Hongyuan Initiates Coverage on XTALPI (02228) with 'Buy' Rating, Comprehensive Layout from Pharmaceuticals to AI4S","url":"https://stock-news.laohu8.com/highlight/detail?id=1195764847","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195764847?lang=en_us&edition=fundamental","pubTime":"2025-12-29 15:42","pubTimestamp":1766994143,"startTime":"0","endTime":"0","summary":"Shenwan Hongyuan released a research report indicating that XTALPI (02228), leveraging its core technologies of \"physical computing + AI + robotics\", has established a complete closed-loop for early...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02228","BK0188","BK1574","BK0028","09939","BK0276","BK0183","BK1161","159938","BK0012","BK1141","BK1617","000166"],"gpt_icon":0},{"id":"1163858514","title":"IPO News | Haina Pharmaceutical Plans Hong Kong Listing, CSRC Requests Additional Details on Fund Usage","url":"https://stock-news.laohu8.com/highlight/detail?id=1163858514","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163858514?lang=en_us&edition=fundamental","pubTime":"2025-12-26 20:50","pubTimestamp":1766753443,"startTime":"0","endTime":"0","summary":"On December 26, the China Securities Regulatory Commission (CSRC) published its \"Requirements for Supplementary Materials for Overseas Listing Filing (December 22, 2025 - December 26, 2025).\" The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","159938","BK1515"],"gpt_icon":0},{"id":"1106101454","title":"HealthyWay Affiliate to Sell 51% Stake in Fujian Jianchen Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1106101454","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106101454?lang=en_us&edition=fundamental","pubTime":"2025-12-26 09:43","pubTimestamp":1766713394,"startTime":"0","endTime":"0","summary":"HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% equity stake in Fujian Jianchen...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09939","02587","BK1515","BK1219","159938","BK1161"],"gpt_icon":0},{"id":"1100984484","title":"Two Top Analysts Reveal Career Moves: Former Guosheng Securities Pharma Chief Zhang Jinyang and Former CMSC Banking Head Wang Xianshuang Join Guolian Minsheng","url":"https://stock-news.laohu8.com/highlight/detail?id=1100984484","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100984484?lang=en_us&edition=fundamental","pubTime":"2025-12-25 17:00","pubTimestamp":1766653240,"startTime":"0","endTime":"0","summary":"In a significant talent acquisition move, Guolian Minsheng Research Institute has welcomed two heavyweight analysts. Zhang Jinyang, formerly the Chief Pharmaceutical Analyst at Guosheng Securities...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1147","159938","601456","002670","01456","BK1161","06099","BK0276","BK0010","BK0188","BK0183","09939","600999","BK0052","BK1574","BK0012","BK0028","BK1564"],"gpt_icon":0},{"id":"1194030810","title":"Guosen Securities: New U.S. Pharmaceutical Supply Chain Regulations Highlight Investment Opportunities in CXO Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1194030810","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194030810?lang=en_us&edition=fundamental","pubTime":"2025-12-25 10:06","pubTimestamp":1766628378,"startTime":"0","endTime":"0","summary":"Guosen Securities released a research report stating that the U.S. Congress recently passed the fiscal year 2026 National Defense Authorization Act (2026 NDAA), which includes revised provisions of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","CXO","BK0183","09939","BK0028","BK1161","BK1574","002736","BK0188","159938","BK1515"],"gpt_icon":0},{"id":"1191612575","title":"HEALTHYWAY INC (02587) Subsidiary to Sell 51% Stake in Fujian Jianchen Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1191612575","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191612575?lang=en_us&edition=fundamental","pubTime":"2025-12-24 17:36","pubTimestamp":1766568967,"startTime":"0","endTime":"0","summary":"HEALTHYWAY INC (02587) announced that on December 24, 2025, its wholly-owned subsidiary, Zhejiang Healthy Way Technology Group Co., Ltd., intends to sell a 51% stake in Fujian Jianchen Pharmaceutical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","BK1574","BK1161","BK1515","02587","BK1219"],"gpt_icon":0},{"id":"1163321221","title":"New Drug Firm Xinji Pharma Files for Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1163321221","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163321221?lang=en_us&edition=fundamental","pubTime":"2025-12-24 15:19","pubTimestamp":1766560775,"startTime":"0","endTime":"0","summary":"Guangzhou Xinji Pharmaceuticals Co., Ltd. (\"Xinji Pharma\") has submitted its listing application to the Hong Kong Stock Exchange's main board, with Haitong International as its sole sponsor. Founded...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","159938","BK1161","HEXmain"],"gpt_icon":0},{"id":"1166596994","title":"Pharma Giants Ramp Up Year-End Deals: $2.5B ALS Drug Acquisition and $1.06B ADC Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=1166596994","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166596994?lang=en_us&edition=fundamental","pubTime":"2025-12-23 20:11","pubTimestamp":1766491860,"startTime":"0","endTime":"0","summary":"On December 22, Shionogi announced plans to acquire Mitsubishi Tanabe Pharma's amyotrophic lateral sclerosis (ALS, commonly known as \"Lou Gehrig's disease\") drug business segment. The deal includes...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK4231","BK1574","BK1161","ADC","BK4080","BK1515"],"gpt_icon":0},{"id":"1181395345","title":"ABBISKO-B (02256): ABBISK Medicine's CSF-1R Inhibitor Beijiemai® Approved by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1181395345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181395345?lang=en_us&edition=fundamental","pubTime":"2025-12-22 16:41","pubTimestamp":1766392862,"startTime":"0","endTime":"0","summary":"On December 22, 2025, ABBISKO-B (02256) announced that its subsidiary, Shanghai ABBISK Biopharmaceutical Co., Ltd. (\"ABBISK Medicine\"), received approval from China's National Medical Products...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","CSF","BK1161","02256","LU2476274308.USD","LU2488822045.USD","159938","BK1574","IE00B543WZ88.USD","LU2476274720.SGD","09939","IE00B5MMRT66.SGD","LU2778985437.USD","BK1515"],"gpt_icon":0},{"id":"1167849227","title":"Qinghai Advances Standardization in Tibetan Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=1167849227","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167849227?lang=en_us&edition=fundamental","pubTime":"2025-12-22 03:40","pubTimestamp":1766346032,"startTime":"0","endTime":"0","summary":"Qinghai Province has made significant progress in standardizing Tibetan medicine, according to a recent meeting on Tibetan medicine standardization. The province has optimized the development...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","09939","159938"],"gpt_icon":0},{"id":"1116587365","title":"Pharmaceutical Stocks Rebound Sharply This Morning with Asymchem and Wuxi Biologics Both Rising Over 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116587365","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116587365?lang=en_us&edition=fundamental","pubTime":"2025-12-19 11:13","pubTimestamp":1766113983,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks showed a notable rebound this morning, led by the CRO and innovative drug sectors. At the time of writing, Asymchem Laboratories (06821) rose 6.07% to HK$76.85, while Wuxi...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","LU0043850808.USD","09939","BK1576","LU0348825331.USD","LU1720050803.USD","LU2039709279.SGD","BK1515","SG9999002463.SGD","02269","BK1610","LU0456846285.SGD","LU0572944931.SGD","BK1574","BK1141","LU0417516738.SGD","LU0516422440.USD","LU0348735423.USD","LU1688375341.USD","BK1161","SG9999002562.SGD","LU0516423174.USD","LU0708995583.HKD","LU0516422952.EUR","LU0823426308.USD","BK0239","LU0320764599.SGD","LU0823426480.USD","LU0051755006.USD","BK0132","LU0516423091.SGD","LU0979878070.USD","LU0307460666.USD","159938","LU0359202008.SGD","002821","LU1328615791.USD","LU0140636845.USD","LU0819121731.USD","06821","LU1242518857.USD","LU3063872942.SGD","LU0039217434.USD","LU0327786744.USD","LU1880383366.USD","LU0588546209.SGD","BK1521","LU0856984785.SGD","LU1242518931.SGD","LU0052750758.USD","LU0181495838.USD","BK1191","LU0417516902.SGD","LU1794554557.SGD","BK1589","LU0456827905.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"1160364014","title":"CMSC: Innovative Drug Industry Chain Remains Key Focus in Pharma Sector, Highlighting Small Nucleic Acid Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1160364014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160364014?lang=en_us&edition=fundamental","pubTime":"2025-12-19 10:50","pubTimestamp":1766112610,"startTime":"0","endTime":"0","summary":"According to a research report by CMSC, the pharmaceutical sector is expected to see structural opportunities in 2026, driven by continued overseas expansion of innovation and differentiated domestic...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","BK0276","BK1147","BK0183","BK0010","BK1564","BK1515","159992","600999","BK0028","06099","BK1161","09939","06978","159938","BK1574"],"gpt_icon":0},{"id":"1190712640","title":"20 Provinces Advance Provincial-Level Medical Insurance Pooling, Accelerating Unified National Pharmaceutical Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190712640","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190712640?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:50","pubTimestamp":1766065840,"startTime":"0","endTime":"0","summary":"During the \"14th Five-Year Plan\" period, China's medical insurance reforms have unleashed sustained institutional dividends—from cross-province direct settlement of medical expenses and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"1108309207","title":"BIOSTAR PHARM-B (02563): First Patient Dosed in U.S. Pivotal Clinical Study of Utidelone for Breast Cancer Brain Metastasis","url":"https://stock-news.laohu8.com/highlight/detail?id=1108309207","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108309207?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:37","pubTimestamp":1765978642,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) announced that its wholly-owned U.S. subsidiary, Biostar Pharma, Inc. (US-Biostar), has completed the first patient dosing in a key overseas clinical study: the U.S. pivotal...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159938","BK1574","02563","09939","BK1515"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0182},{"period":"1month","weight":-0.0428},{"period":"3month","weight":-0.1253},{"period":"6month","weight":0.0062},{"period":"1year","weight":0.0605},{"period":"ytd","weight":0.0605}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"serverTime":1767620494036,"compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS,159938,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎国际,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股价,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股市,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票价格,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票交易,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票购买,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction